This site is intended for health professionals only

Published on 10 July 2007

Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
VTE deaths “avoidable”
LEO Pharma launches Enstilar®, the first fixed-combination foam spray for the treatment of plaque psoriasis
Fluzone® High-Dose vaccine data
Marketing authorisation for Selincro
Improving the safety of medication use

COPD drug access widened

teaser

European regulators have expanded the number of patients eligible for treatment with GlaxoSmithKline’s chronic obstructive pulmonary disorder drug Seretide



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
Janssen-Cilag’s Stelara approved by NICE
4
Merck agrees huge Vioxx settlement
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
Share
RELATED ARTICLES
Pharmacist-directed coagulation service supported
Concerns over new MRSA strains
The pharmacist workforce and its future
NICE recommends MabThera for NHL
Survey examines medical device makers